Advanced cancer
Information
- Disease name
- Advanced cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03459222 | Active, not recruiting | Phase 1/Phase 2 | An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread | May 30, 2018 | November 10, 2026 |
| NCT03561207 | Active, not recruiting | 3D Prediction of Patient-Specific Response | June 11, 2018 | December 2024 | |
| NCT05990920 | Active, not recruiting | Phase 1 | Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy | August 23, 2023 | December 2024 |
| NCT02743494 | Active, not recruiting | Phase 3 | An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer | July 14, 2016 | October 11, 2025 |
| NCT03761017 | Active, not recruiting | Phase 1 | MGD019 DART® Protein in Unresectable/Metastatic Cancer | December 12, 2018 | December 2024 |
| NCT02069067 | Active, not recruiting | Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated | December 2011 | December 2023 | |
| NCT05663710 | Active, not recruiting | Phase 1/Phase 2 | Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC | June 30, 2023 | October 30, 2027 |
| NCT03994601 | Active, not recruiting | Phase 1/Phase 2 | An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers | September 6, 2019 | May 14, 2025 |
| NCT03568058 | Active, not recruiting | Phase 1 | Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers | July 26, 2018 | December 2025 |
| NCT05103358 | Active, not recruiting | Phase 2 | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | February 15, 2022 | December 31, 2025 |
| NCT03775525 | Active, not recruiting | Phase 1 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer | March 1, 2019 | December 2023 |
| NCT03352531 | Active, not recruiting | Phase 1 | Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors | December 22, 2017 | October 2023 |
| NCT03446040 | Active, not recruiting | Phase 1/Phase 2 | An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread | March 8, 2018 | April 15, 2025 |
| NCT03674567 | Active, not recruiting | Phase 1/Phase 2 | Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab | September 25, 2018 | January 2025 |
| NCT05047042 | Active, not recruiting | N/A | A Feasibility Study of a Virtual Rehabilitation and Physical Activity Program for People With Advanced Cancer | January 17, 2022 | October 2024 |
| NCT05025085 | Active, not recruiting | Phase 1 | A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors | October 4, 2021 | September 30, 2025 |
| NCT04991480 | Active, not recruiting | Phase 1 | A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors | September 13, 2021 | August 2025 |
| NCT03440437 | Active, not recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies | April 16, 2018 | June 2024 |
| NCT03307785 | Active, not recruiting | Phase 1 | Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 | October 12, 2017 | August 30, 2024 |
| NCT01087554 | Active, not recruiting | Phase 1 | Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | March 2010 | August 18, 2026 |
| NCT03833479 | Active, not recruiting | Phase 2 | TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) | June 28, 2019 | December 2025 |
| NCT05840510 | Active, not recruiting | Phase 1/Phase 2 | Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) | August 7, 2023 | June 30, 2026 |
| NCT03375437 | Active, not recruiting | N/A | RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. | February 15, 2018 | January 15, 2025 |
| NCT04435444 | Active, not recruiting | N/A | Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer | June 15, 2020 | June 2024 |
| NCT03829501 | Active, not recruiting | Phase 1/Phase 2 | Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer | January 28, 2019 | August 5, 2024 |
| NCT03425565 | Active, not recruiting | Phase 2 | A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer | February 18, 2019 | September 2024 |
| NCT03510104 | Active, not recruiting | Phase 1 | Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors | May 22, 2018 | July 2024 |
| NCT04945928 | Active, not recruiting | N/A | Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC | August 27, 2021 | June 5, 2026 |
| NCT03909334 | Active, not recruiting | Phase 2 | Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | July 25, 2019 | June 2024 |
| NCT03526679 | Active, not recruiting | Phase 1/Phase 2 | Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma | July 12, 2018 | June 30, 2023 |
| NCT04339062 | Active, not recruiting | Phase 1/Phase 2 | Cemiplimab in AlloSCT/SOT Recipients With CSCC | November 3, 2020 | January 1, 2025 |
| NCT02455505 | Active, not recruiting | Identifying Family Members in Need of Support While Caregiving and After Loss | May 2015 | May 2027 | |
| NCT04864418 | Active, not recruiting | Phase 1 | AST-021p Study in Advanced Solid Tumors | June 9, 2021 | November 2023 |
| NCT03013218 | Active, not recruiting | Phase 1 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | February 3, 2017 | December 1, 2024 |
| NCT04330664 | Active, not recruiting | Phase 1/Phase 2 | Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) | April 22, 2020 | December 24, 2024 |
| NCT04065984 | Active, not recruiting | N/A | Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES) | April 14, 2019 | March 1, 2026 |
| NCT03029403 | Active, not recruiting | Phase 2 | Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer | February 12, 2018 | February 12, 2025 |
| NCT04310345 | Active, not recruiting | N/A | Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents | March 31, 2021 | February 2025 |
| NCT04012749 | Active, not recruiting | N/A | UC Health Care Planning Study | October 25, 2019 | September 15, 2024 |
| NCT03042156 | Active, not recruiting | Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy | January 10, 2017 | June 2024 | |
| NCT01187199 | Active, not recruiting | Phase 1 | Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer | August 19, 2010 | April 30, 2026 |
| NCT04861987 | Active, not recruiting | Phase 1 | A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors | June 18, 2021 | August 10, 2024 |
| NCT04837196 | Active, not recruiting | Phase 1/Phase 2 | Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen | December 6, 2021 | June 30, 2024 |
| NCT04121676 | Active, not recruiting | Phase 1 | Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer | September 26, 2019 | June 2027 |
| NCT00761618 | Active, not recruiting | Phase 2 | Intrapleural Catheter Daily Versus Three Times a Week Drainage | August 22, 2008 | August 31, 2024 |
| NCT04270864 | Active, not recruiting | Phase 1 | Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers | April 10, 2020 | February 2026 |
| NCT03369223 | Active, not recruiting | Phase 1/Phase 2 | A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors | December 6, 2017 | September 19, 2024 |
| NCT05298592 | Active, not recruiting | Phase 1 | A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors | March 31, 2022 | July 15, 2024 |
| NCT06107868 | Active, not recruiting | Phase 1 | Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer | March 20, 2024 | December 4, 2026 |
| NCT02711553 | Active, not recruiting | Phase 2 | A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer | May 19, 2016 | December 31, 2025 |
| NCT03763032 | Active, not recruiting | N/A | Psychosocial Intervention in Latino Patients With Advanced Cancer | January 23, 2018 | July 2024 |
| NCT00488072 | Active, not recruiting | Phase 2 | Effects of Mirtazapine on Appetite in Advanced Cancer Patients | September 20, 2006 | December 31, 2025 |
| NCT03195699 | Active, not recruiting | Phase 1 | Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers | November 15, 2017 | December 1, 2024 |
| NCT03177291 | Active, not recruiting | Phase 1 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | September 26, 2017 | June 2024 |
| NCT03667716 | Active, not recruiting | Phase 1 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | September 6, 2018 | May 31, 2024 |
| NCT05162443 | Approved for marketing | Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation | |||
| NCT00710736 | Completed | Phase 1 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | June 2008 | April 2011 |
| NCT00736372 | Completed | Phase 1 | A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer | June 2008 | August 2009 |
| NCT00741403 | Completed | Phase 1 | A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies | August 2008 | December 2016 |
| NCT00761644 | Completed | Phase 1 | Doxil, Bevacizumab and Temsirolimus Trial | August 21, 2008 | March 28, 2019 |
| NCT00770731 | Completed | Phase 1 | Study of Temsirolimus, Topotecan, and Bortezomib | September 2008 | November 2012 |
| NCT00785226 | Completed | Phase 1/Phase 2 | RDEA119 and Sorafenib Combination Dose Escalation Study | November 2008 | April 2012 |
| NCT00798252 | Completed | Phase 1 | Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers | March 2009 | May 2015 |
| NCT00833326 | Completed | Phase 1 | A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer | January 2009 | July 2010 |
| NCT00862524 | Completed | Phase 1/Phase 2 | A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer | March 2009 | February 2011 |
| NCT00878267 | Completed | Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study | March 2009 | September 2011 | |
| NCT00881569 | Completed | Phase 1 | Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017 | March 2009 | September 2011 |
| NCT00895128 | Completed | Phase 1 | Study of Erlotinib in Combination With Dasatinib | April 2009 | |
| NCT00895687 | Completed | Phase 1 | Study of Erlotinib in Combination With Bortezomib | April 2009 | |
| NCT00907738 | Completed | Phase 2 | A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) | August 2005 | June 2010 |
| NCT00933361 | Completed | Phase 1/Phase 2 | Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study | June 2009 | December 2011 |
| NCT00940381 | Completed | Phase 1 | Sirolimus and Cetuximab in Advanced Malignancies | July 2009 | May 2014 |
| NCT00949390 | Completed | Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials | July 2009 | April 2016 | |
| NCT00951262 | Completed | Phase 4 | Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China | February 2009 | June 2010 |
| NCT00951574 | Completed | Phase 3 | Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) | October 2003 | July 2008 |
| NCT00955812 | Completed | Phase 1 | STAT3 Inhibitor for Solid Tumors | June 2009 | November 2012 |
| NCT00965341 | Completed | Phase 3 | Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | September 2009 | September 2012 |
| NCT00970125 | Completed | N/A | Using Video Images to Improve Advance Care Planning in Patients With Cancer | August 2009 | June 2011 |
| NCT00980122 | Completed | Aggressiveness of Care at the End of Life in Cancer Patients | March 2008 | ||
| NCT00980239 | Completed | Phase 1 | HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | September 2009 | August 2015 |
| NCT00994578 | Completed | N/A | Intervention Study of Communication in Oncologist-Patient Encounters | November 2010 | April 2014 |
| NCT01015222 | Completed | Phase 1 | Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies | November 2009 | May 27, 2021 |
| NCT01048008 | Completed | Phase 1 | Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer | September 2010 | November 2013 |
| NCT01054313 | Completed | Phase 1 | Docetaxel and Sirolimus in Patients With Advanced Malignancies | January 2010 | October 2014 |
| NCT01072266 | Completed | Phase 1 | A Dose-escalation Study in Subjects With Advanced Malignancies | January 2010 | January 2013 |
| NCT01081301 | Completed | Phase 2 | Living With Hope Program for Rural Women Caregivers | January 2009 | March 2012 |
| NCT01113476 | Completed | Phase 1 | Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies | April 27, 2010 | August 12, 2022 |
| NCT01115790 | Completed | Phase 1 | A Phase 1 Study in Participants With Advanced Cancer | February 2010 | January 2016 |
| NCT01143779 | Completed | Phase 1 | FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib | June 2010 | December 27, 2021 |
| NCT01152203 | Completed | Phase 1 | Bendamustine and Bevacizumab for Advanced Cancers | June 2010 | May 2014 |
| NCT01158404 | Completed | Phase 1 | Notch Inhibitor in Advanced Cancer | July 2010 | August 2012 |
| NCT01197170 | Completed | Phase 1 | Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance | September 7, 2010 | January 13, 2021 |
| NCT05910541 | Completed | N/A | The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers | January 2, 2020 | March 31, 2020 |
| NCT01212107 | Completed | Phase 1 | A Phase 1 Study of LY2874455 in Participants With Advanced Cancer | December 2010 | February 2015 |
| NCT01214629 | Completed | Phase 1 | A Study for Participants With Advanced Cancer | July 2007 | May 2012 |
| NCT01214642 | Completed | Phase 1 | A Dose-Escalation Study for Patients With Advanced Cancer | May 2008 | June 2012 |
| NCT01226485 | Completed | Phase 1 | A Study in Advanced Cancer | September 2010 | October 2017 |
| NCT01241929 | Completed | N/A | Using Videos in Advance Care Planning for Patients With Advanced Cancer | April 2009 | April 2012 |
| NCT01245621 | Completed | N/A | Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III) | October 2010 | September 2013 |
| NCT01262651 | Completed | Phase 3 | Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer | November 25, 2010 | July 2, 2015 |
| NCT01287520 | Completed | Phase 1 | A Study of LY2090314 in Patients With Advanced or Metastatic Cancer | November 2007 | April 2011 |
| NCT01287546 | Completed | Phase 1 | A Study of LY2875358 in Participants With Advanced Cancer | April 13, 2010 | October 26, 2016 |
| NCT01295632 | Completed | Phase 1 | Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049) | February 2011 | August 2015 |
| NCT01296568 | Completed | Phase 1 | C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors | February 2011 | February 2012 |
| NCT01337089 | Completed | Phase 3 | Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain | January 19, 2011 | January 27, 2016 |
| NCT01339871 | Completed | Phase 1 | Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies | April 20, 2011 | June 7, 2017 |
| NCT01358110 | Completed | N/A | Emergency Department-Based Palliative Care for Advanced Cancer Patients | May 2011 | January 2015 |
| NCT01361607 | Completed | Phase 3 | Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer | May 27, 2011 | November 24, 2014 |
| NCT01367795 | Completed | Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life | July 2010 | October 2014 | |
| NCT01393990 | Completed | Phase 1 | A Study of LY2228820 in Participants With Advanced Cancer | September 4, 2008 | December 14, 2013 |
| NCT01394016 | Completed | Phase 1 | A Phase 1 Study of LY2835219 In Participants With Advanced Cancer | December 7, 2009 | April 12, 2022 |
| NCT01417065 | Completed | Early Phase 1 | Temsirolimus In Phase 0 | August 2010 | |
| NCT01423903 | Completed | Phase 1 | Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer | February 2010 | April 2013 |
| NCT01424566 | Completed | Phase 3 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | June 29, 2012 | December 28, 2015 |
| NCT01443390 | Completed | An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer | September 2011 | March 2013 | |
| NCT01444157 | Completed | Phase 3 | Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients | October 2011 | April 2014 |
| NCT01462383 | Completed | The Role of the EKG in Anticancer Drug Development | January 2011 | November 2011 | |
| NCT01463982 | Completed | Phase 1 | Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies | December 2010 | December 2013 |
| NCT01505153 | Completed | Phase 1 | Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer | February 2012 | April 13, 2017 |
| NCT01524224 | Completed | Phase 1 | A Dose-Escalation Study in Participants With Advanced Cancer | January 2008 | January 2016 |
| NCT01538537 | Completed | Phase 1 | Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer | August 2006 | January 2012 |
| NCT01538563 | Completed | Phase 1 | Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer | June 2006 | November 2011 |
| NCT01539733 | Completed | N/A | Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer | March 2010 | April 2017 |
| NCT01543841 | Completed | Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood | August 2012 | January 2014 | |
| NCT00085787 | Completed | Phase 1 | A Study of ARRY-142886 in Patients With Advanced Cancer | June 2004 | February 2007 |
| NCT01567345 | Completed | N/A | Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow | January 14, 2009 | October 2010 |
| NCT01576406 | Completed | Phase 1 | Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients | July 2012 | June 2016 |
| NCT01583777 | Completed | Phase 1 | Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer | September 2013 | April 2015 |
| NCT01596140 | Completed | Phase 1 | Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer | December 18, 2012 | June 1, 2020 |
| NCT01644968 | Completed | Phase 1 | Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer | November 2003 | April 2017 |
| NCT01655225 | Completed | Phase 1 | A Study of LY3023414 in Participants With Advanced Cancer | July 31, 2012 | February 2, 2022 |
| NCT01660360 | Completed | Phase 1 | Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer | November 2011 | September 2013 |
| NCT05364905 | Completed | Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma | May 9, 2022 | November 22, 2022 | |
| NCT01693991 | Completed | Phase 1 | Randomized Controlled Trial of the Meaning-Making Intervention (MMi) | October 2012 | December 2013 |
| NCT05315427 | Completed | Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer | May 2, 2022 | January 5, 2023 | |
| NCT01833923 | Completed | Phase 1 | A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics | May 2011 | October 2015 |
| NCT01863485 | Completed | Phase 1 | Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China | May 2013 | May 2016 |
| NCT01864681 | Completed | Phase 2 | Combination of Metformin With Gefitinib to Treat NSCLC | May 2013 | June 4, 2018 |
| NCT01901237 | Completed | N/A | Yoga for Adolescent and Young Adult Non-Curative Cancer Patients | September 2013 | June 13, 2017 |
| NCT01954316 | Completed | Phase 1 | A Study of CFI-400945 Fumarate in Patients With Advanced Cancer | March 2014 | July 22, 2021 |
| NCT01976143 | Completed | Phase 1 | A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety | February 2014 | September 2016 |
| NCT01976910 | Completed | Phase 1 | Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" | September 2010 | October 2013 |
| NCT01977638 | Completed | Phase 1 | Phase 1 Trial of CXD101 in Patients With Advanced Cancer | February 14, 2014 | October 14, 2022 |
| NCT05137782 | Completed | N/A | The Science of the Art of Palliative Care | January 3, 2023 | November 30, 2023 |
| NCT02014909 | Completed | Phase 1 | A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors | January 2014 | June 5, 2017 |
| NCT02082210 | Completed | Phase 1/Phase 2 | A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer | March 7, 2014 | January 24, 2018 |
| NCT00147225 | Completed | Phase 1/Phase 2 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | August 2005 | March 2013 |
| NCT05103488 | Completed | N/A | Comprehensive Palliative Care for Cancer Patients in Vietnam | May 7, 2020 | April 30, 2021 |
| NCT02193633 | Completed | Phase 1 | A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. | April 26, 2013 | November 15, 2017 |
| NCT02219711 | Completed | Phase 1 | Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer | August 2014 | April 27, 2022 |
| NCT02245204 | Completed | Phase 1 | Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers | September 2014 | October 2016 |
| NCT02332317 | Completed | N/A | Early, Integrated, Specialized Palliative Rehabilitation | December 2014 | June 2018 |
| NCT02338622 | Completed | Phase 1 | Trial of Olaparib in Combination With AZD5363 (ComPAKT) | March 31, 2014 | March 21, 2017 |
| NCT04975256 | Completed | Phase 1 | Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) | August 12, 2021 | November 15, 2022 |
| NCT02357108 | Completed | N/A | Message: Study of Patients' Perception of Physician's Compassion | May 2013 | August 2015 |
| NCT02383212 | Completed | Phase 1 | Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies | February 2, 2015 | November 18, 2019 |
| NCT02383368 | Completed | Phase 1 | A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma | March 23, 2015 | April 27, 2018 |
| NCT02407990 | Completed | Phase 1 | Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors | June 2, 2015 | August 12, 2020 |
| NCT02418624 | Completed | Phase 1 | Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer | May 2015 | January 2019 |
| NCT02430467 | Completed | N/A | Caregiver-Guided Pain Management Training in Palliative Care | July 2015 | October 4, 2019 |
| NCT04869267 | Completed | N/A | Acceptance and Commitment Therapy in Patients With Advanced Lung Cancer | July 1, 2021 | January 7, 2022 |
| NCT02470715 | Completed | Identifying Molecular Drivers of Cancer | April 2014 | May 22, 2018 | |
| NCT02507544 | Completed | Phase 1 | A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer | September 2015 | May 20, 2019 |
| NCT02529553 | Completed | Phase 1 | A Study of LY3076226 in Participants With Advanced or Metastatic Cancer | September 2015 | March 28, 2018 |
| NCT02583932 | Completed | Phase 3 | Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer | October 2015 | August 2020 |
| NCT02642016 | Completed | Phase 1 | A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors | December 2015 | June 4, 2019 |
| NCT02655289 | Completed | N/A | Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients | February 2016 | March 2018 |
| NCT02658890 | Completed | Phase 1/Phase 2 | An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread | April 14, 2016 | October 26, 2021 |
| NCT04772690 | Completed | N/A | Balance, Activity and Quality of Life | May 1, 2021 | December 24, 2021 |
| NCT04738305 | Completed | N/A | Feasibility of Dignity Therapy Intervention on Cancer Patients in Charge to an Hospital Palliative Care Unit. | June 2016 | December 2017 |
| NCT02703298 | Completed | Phase 1 | Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients | March 25, 2016 | May 3, 2018 |
| NCT02712229 | Completed | N/A | A Primary Palliative Care Intervention for Patients With Advanced Cancer | July 27, 2016 | October 15, 2020 |
| NCT02737475 | Completed | Phase 1/Phase 2 | An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread | June 17, 2016 | November 2, 2020 |
| NCT02745769 | Completed | Phase 1 | A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents | October 21, 2016 | January 22, 2019 |
| NCT04678921 | Completed | Phase 1 | Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors | December 17, 2020 | November 21, 2022 |
| NCT04640714 | Completed | N/A | Care Transition Intervention for Patients With Cancer | January 7, 2021 | July 14, 2021 |
| NCT02777710 | Completed | Phase 1 | Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers | June 2016 | December 2019 |
| NCT02778126 | Completed | Phase 1 | A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer | September 22, 2016 | July 27, 2017 |
| NCT04626349 | Completed | N/A | International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their Families | February 24, 2021 | November 30, 2023 |
| NCT04606940 | Completed | Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) | October 19, 2020 | October 12, 2021 | |
| NCT04480008 | Completed | N/A | Resilient Living Program for Patients With Advanced Cancer and Their Caregivers | July 15, 2020 | December 27, 2021 |
| NCT02825563 | Completed | Phase 1 | A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients | June 2016 | August 15, 2018 |
| NCT02841124 | Completed | N/A | Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies. | January 2011 | August 2011 |
| NCT02857270 | Completed | Phase 1 | A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer | September 29, 2016 | October 24, 2022 |
| NCT02860780 | Completed | Phase 1 | A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer | August 10, 2016 | May 15, 2017 |
| NCT02884726 | Completed | Phase 1 | Phase 1 Study of Mesothelin-ADC | October 14, 2016 | September 6, 2017 |
| NCT04471818 | Completed | Phase 1/Phase 2 | Ketamine or Placebo in Patients With Major Depression and Advanced Cancer | September 19, 2019 | July 30, 2023 |
| NCT02919696 | Completed | Phase 1 | A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers | August 7, 2017 | September 3, 2019 |
| NCT02930876 | Completed | Phase 2 | Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients | July 2016 | February 8, 2017 |
| NCT02944136 | Completed | N/A | Collaborative Care Intervention for Cancer Caregivers | December 2016 | March 7, 2023 |
| NCT02957565 | Completed | N/A | Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit | November 3, 2016 | January 2, 2020 |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT02980289 | Completed | DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. | February 2016 | July 1, 2018 | |
| NCT02992171 | Completed | N/A | Primary Palliative Care for Patients With Advanced Hematologic Malignancies | May 2, 2017 | March 19, 2020 |
| NCT04386057 | Completed | Phase 2 | LY3214996 +/- HCQ in Pancreatic Cancer | May 27, 2020 | February 5, 2024 |
| NCT02996110 | Completed | Phase 2 | A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma | February 2, 2017 | November 23, 2021 |
| NCT04336124 | Completed | Phase 1 | Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients | May 25, 2020 | April 8, 2022 |
| NCT04335253 | Completed | Phase 1 | First-In-Human Study of EOS884448 in Participants With Advanced Cancers. | February 18, 2020 | April 7, 2022 |
| NCT03027284 | Completed | Phase 1 | A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer | February 3, 2017 | March 17, 2020 |
| NCT03040102 | Completed | N/A | Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers | March 9, 2017 | February 1, 2019 |
| NCT03094780 | Completed | N/A | Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers | July 2016 | February 21, 2019 |
| NCT03098550 | Completed | Phase 1/Phase 2 | A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread | June 15, 2017 | July 6, 2020 |
| NCT04303091 | Completed | N/A | The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients | March 2, 2018 | December 20, 2018 |
| NCT03104699 | Completed | Phase 1/Phase 2 | Study of AGEN2034 in Advanced Tumors and Cervical Cancer | April 11, 2017 | June 15, 2022 |
| NCT04257617 | Completed | Phase 1 | A Trial of ZL-1201 in Subjects With Advanced Cancer | May 11, 2020 | January 19, 2023 |
| NCT04254926 | Completed | N/A | Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients | April 6, 2019 | August 18, 2021 |
| NCT00278902 | Completed | Phase 1 | A Study of ARRY-334543 in Patients With Advanced Cancer | January 2006 | June 2009 |
| NCT03137121 | Completed | Phase 2/Phase 3 | Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients | July 12, 2017 | September 15, 2020 |
| NCT03140137 | Completed | Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases | January 21, 2017 | January 4, 2018 | |
| NCT03168035 | Completed | Phase 1 | Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma | November 2013 | April 2017 |
| NCT03181854 | Completed | N/A | Randomized Controlled Trial of Integrated Early Palliative Care | September 8, 2017 | June 30, 2019 |
| NCT03192943 | Completed | Phase 1 | A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors | June 23, 2017 | December 11, 2018 |
| NCT02666183 | Completed | N/A | Online Information and Support for Distance Caregivers | April 6, 2016 | April 16, 2020 |
| NCT03765099 | Completed | N/A | Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents | February 21, 2019 | December 31, 2022 |
| NCT03780816 | Completed | Variation in Cancer Centers' End-of-Life Quality | July 5, 2019 | July 15, 2021 | |
| NCT00421135 | Completed | Phase 1 | A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer | February 2006 | October 2007 |
| NCT03792750 | Completed | Phase 1/Phase 2 | A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors | December 31, 2018 | December 18, 2020 |
| NCT00423410 | Completed | Phase 1 | A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer | December 2006 | September 2009 |
| NCT03833817 | Completed | N/A | Patient-caregiver Communication Intervention for Prognostic Understanding | September 20, 2020 | January 18, 2022 |
| NCT03823313 | Completed | N/A | Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention | December 10, 2018 | August 28, 2019 |
| NCT00423722 | Completed | N/A | Parenteral Hydration in Advanced Cancer Patients | January 9, 2007 | May 2013 |
| NCT00424099 | Completed | Phase 2/Phase 3 | Methylphenidate and a Nursing Telephone Intervention for Fatigue | January 9, 2007 | November 22, 2021 |
| NCT00429234 | Completed | Phase 1 | Gemcitabine and Dasatinib in Advanced Solid Tumors | January 2007 | February 2013 |
| NCT00438620 | Completed | The Feasibility of Physical Activity in Advanced Cancer Patients | October 2006 | ||
| NCT00450541 | Completed | Fatigue Experience in Cancer Patients | March 2007 | April 2010 | |
| NCT00477243 | Completed | Locus of Control and Spirituality in Palliative Care Patients | June 3, 2004 | August 11, 2017 | |
| NCT00489593 | Completed | Phase 1 | Olanzapine in Patients With Advanced Cancer and Weight Loss | October 2006 | December 2013 |
| NCT00493714 | Completed | Delirium Recall in Advanced Cancer Patients | July 2005 | December 2007 | |
| NCT00505544 | Completed | Measuring Sleep Disturbance Among Cancer Patients | August 2005 | July 11, 2022 | |
| NCT00507754 | Completed | Latent Tuberculosis Infection in Cancer Patients | June 2007 | May 2011 | |
| NCT00507962 | Completed | Phase 1 | Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement | March 2005 | May 2011 |
| NCT00508326 | Completed | Phase 1 | Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | October 2005 | October 2010 |
| NCT00512291 | Completed | N/A | Subcutaneous Olanzapine for Hyperactive or Mixed Delirium | June 2005 | August 2009 |
| NCT00513162 | Completed | Phase 1 | Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases | July 2007 | |
| NCT00106626 | Completed | Phase 1 | Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors | August 2005 | December 2007 |
| NCT00518739 | Completed | Phase 1 | MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) | February 2007 | December 2008 |
| NCT00530907 | Completed | Phase 1 | Valproic Acid and Bevacizumab in Patients With Advanced Cancer | June 2007 | November 2013 |
| NCT00543153 | Completed | The Exceptional Patient in Cancer Care | August 2007 | August 2010 | |
| NCT00543504 | Completed | Phase 1 | Bevacizumab in Multiple Phase I Combinations | October 10, 2007 | April 29, 2020 |
| NCT00551850 | Completed | Phase 1 | A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients | October 2007 | May 2010 |
| NCT00559182 | Completed | Phase 1 | A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001) | December 5, 2007 | July 9, 2010 |
| NCT00581880 | Completed | Measuring Hope and Hopelessness in Cancer | January 2005 | January 2009 | |
| NCT06323135 | Completed | Nutrition Assessment in Advanced Cancer Patients | September 17, 2019 | September 11, 2023 | |
| NCT00591890 | Completed | Phase 1 | Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans | October 2007 | March 2009 |
| NCT06118125 | Completed | Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement | June 1, 2019 | September 1, 2022 | |
| NCT00608803 | Completed | Phase 1 | Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors | January 2008 | January 2009 |
| NCT00610194 | Completed | Phase 1 | Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients | November 28, 2007 | August 1, 2012 |
| NCT00610493 | Completed | Phase 1 | Bevacizumab and Temsirolimus in Patients With Advanced Malignancy | January 25, 2008 | November 28, 2017 |
| NCT00621725 | Completed | Phase 1 | Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours | January 2008 | January 2014 |
| NCT00625638 | Completed | N/A | Interactive Voice Response System in Advanced Cancer Patients | January 28, 2008 | December 2, 2022 |
| NCT00629200 | Completed | Phase 1 | Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies | September 13, 2006 | February 10, 2010 |
| NCT00629473 | Completed | Phase 1 | Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies | July 2007 | April 2013 |
| NCT00634257 | Completed | Spirituality/Religiosity in Patients and Caregivers | February 22, 2008 | February 10, 2022 | |
| NCT00637702 | Completed | Phase 1 | A Study of ARRY-334543 in Patients With Advanced Cancer | February 2008 | October 2012 |
| NCT00656461 | Completed | Phase 1 | Phase 1 Study of MKC-1 in Patients With Advanced Cancer | March 2008 | November 2009 |
| NCT00658671 | Completed | Phase 1 | A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer | April 2008 | June 2012 |
| NCT00664170 | Completed | Phase 1 | A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer | April 2008 | April 2009 |
| NCT00667485 | Completed | Phase 1 | Rapamycin Plus Bevacizumab in Advanced Cancers | April 2008 | May 2012 |
| NCT00682994 | Completed | N/A | Patient and Family Decision Making in the Palliative Care Setting | March 2008 | August 2012 |
| NCT00687349 | Completed | Phase 3 | Improving Clinician Communication Skills (ICCS) | April 2007 | March 2013 |
| NCT00687505 | Completed | Phase 1 | Safety Study of FP-1039 To Treat Cancer | July 2008 | June 2011 |
| NCT00688038 | Completed | Phase 4 | Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy | May 13, 2008 | September 12, 2017 |
| NCT00697632 | Completed | Phase 1 | Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies | June 2008 | January 2019 |
| NCT00698841 | Completed | Phase 2 | Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors | February 2009 | February 2010 |
| NCT00707135 | Completed | Phase 1 | Rapamycin in Advanced Cancers | June 2005 | December 2008 |
| NCT00708591 | Completed | Phase 1 | Study of Rapamycin Plus Ketoconazole in Advanced Cancers | October 2004 | December 2008 |
| NCT00708773 | Completed | Phase 1 | Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors | February 2006 | August 2016 |
| NCT00709176 | Completed | N/A | Outcomes of Triaged Family Care in Advanced Cancer | June 2005 | May 2010 |
| NCT03475251 | Completed | Phase 1 | A Study of CS1003 in Subjects With Advanced Solid Tumors | May 9, 2018 | May 31, 2021 |
| NCT03507166 | Completed | Phase 2 | A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer | December 28, 2017 | October 29, 2018 |
| NCT03980041 | Completed | Phase 2 | Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) | September 25, 2019 | November 15, 2022 |
| NCT03532997 | Completed | N/A | Extra Layer Of Support | October 1, 2018 | January 7, 2020 |
| NCT03536728 | Completed | Phase 1 | Oral AMXT 1501 Dicaprate in Combination With DFMO | June 12, 2018 | April 21, 2023 |
| NCT03979118 | Completed | Exercise Prescription in Patients With Bone Metastases | October 15, 2019 | January 31, 2022 | |
| NCT03954067 | Completed | Phase 1 | A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors | August 8, 2019 | April 19, 2024 |
| NCT03565757 | Completed | N/A | Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced Cancer | July 19, 2018 | December 31, 2020 |
| NCT03579628 | Completed | Phase 1 | AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors | April 5, 2018 | February 20, 2022 |
| NCT03941262 | Completed | Phase 1 | Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy | July 15, 2019 | February 17, 2023 |
| NCT00408226 | Completed | Phase 1/Phase 2 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | October 2006 | January 2012 |
| NCT03610243 | Completed | N/A | Patient-centered Self-administered Acupressure for Fatigue Management in Chinese Advanced Cancer Patients | August 7, 2018 | May 31, 2019 |
| NCT03936959 | Completed | Phase 1 | A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer | May 24, 2019 | April 29, 2021 |
| NCT03661632 | Completed | Phase 1 | An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors | September 11, 2018 | December 29, 2020 |
| NCT03668847 | Completed | Phase 2 | DM-CHOC-PEN for Brain Tumors in AYA Subjects | January 1, 2019 | September 30, 2021 |
| NCT03851146 | Completed | Phase 1 | A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours | November 24, 2016 | April 1, 2022 |
| NCT03714958 | Completed | Phase 1 | Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type | December 20, 2018 | September 12, 2023 |
| NCT03717298 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | October 30, 2018 | January 20, 2023 |
| NCT03837132 | Completed | Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer | October 15, 2018 | June 30, 2021 | |
| NCT03730142 | Completed | Phase 1 | A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma | October 25, 2018 | July 25, 2020 |
| NCT03745807 | Completed | Phase 1 | An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors | April 9, 2019 | December 18, 2019 |
| NCT03751995 | Completed | N/A | POEM (Practice of Embracing Each Moment) Study (Delivery Science) | October 31, 2018 | April 29, 2020 |
| NCT03203876 | Completed | Phase 1 | A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors | July 14, 2017 | August 6, 2020 |
| NCT03207360 | Completed | N/A | Pain Coping Skills and Meaning-Centered Intervention | November 17, 2017 | February 11, 2020 |
| NCT04200963 | Completed | Phase 1 | A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma | December 18, 2019 | July 18, 2023 |
| NCT04193319 | Completed | Phase 1 | Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects | July 19, 2019 | September 12, 2019 |
| NCT04149704 | Completed | N/A | Videos for Advance Care Planning in Young Adults | December 13, 2019 | May 5, 2022 |
| NCT03252678 | Completed | N/A | Efficacy of Self-education Program for Advanced Care Planning(RCT) | August 17, 2017 | February 28, 2018 |
| NCT03254173 | Completed | Phase 2/Phase 3 | Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia | March 26, 2018 | October 17, 2019 |
| NCT04148937 | Completed | Phase 1 | A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer | January 16, 2020 | June 20, 2022 |
| NCT03260712 | Completed | Phase 2 | Pembrolizumab in Biliary Tract Cancer | January 7, 2020 | August 31, 2023 |
| NCT03285633 | Completed | N/A | Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer | January 3, 2018 | September 8, 2018 |
| NCT03312842 | Completed | Phase 1 | A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors | October 19, 2017 | February 16, 2022 |
| NCT03316157 | Completed | N/A | Exercise and Nutritional Rehabilitation in Patients With Cancer | January 30, 2018 | July 3, 2019 |
| NCT03323489 | Completed | N/A | Celiac Plexus Radio-Surgery for Pain Management | January 1, 2018 | May 1, 2022 |
| NCT04071262 | Completed | Phase 1 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer | December 20, 2019 | August 30, 2021 |
| NCT03325985 | Completed | N/A | Emergency Medicine Palliative Care Access | March 28, 2018 | August 24, 2023 |
| NCT03335540 | Completed | Phase 1 | An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment | May 7, 2018 | August 25, 2021 |
| NCT03356223 | Completed | Phase 2 | Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 | February 5, 2018 | December 5, 2022 |
| NCT03371004 | Completed | Phase 1 | DM-CHOC-PEN Plus Radiation for Brain Tumors | February 5, 2016 | October 1, 2022 |
| NCT00385476 | Completed | Cancer Patients' Medication Knowledge in the Emergency Center | August 2005 | February 2009 | |
| NCT03408314 | Completed | N/A | The PediQUEST Response Intervention Study | March 1, 2018 | September 14, 2022 |
| NCT03411200 | Completed | N/A | Patient Activation Through Counseling, Exercise and Mobilization | April 4, 2018 | July 1, 2020 |
| NCT03432247 | Completed | N/A | Pain Management Support Study for Patients With Advanced Cancer | February 1, 2018 | December 31, 2021 |
| NCT05407844 | Enrolling by invitation | N/A | Community Health Worker Based Intervention to Improve Palliative Care | November 2, 2023 | September 1, 2027 |
| NCT04289155 | No longer available | Individual Patient Compassionate Use of GX-I7 | |||
| NCT02889445 | No longer available | A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers | |||
| NCT06090513 | Not yet recruiting | Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients | October 18, 2023 | October 18, 2025 | |
| NCT06117709 | Not yet recruiting | N/A | Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing | August 2024 | April 30, 2025 |
| NCT06346197 | Not yet recruiting | Phase 3 | Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas | May 15, 2024 | May 15, 2028 |
| NCT05749549 | Not yet recruiting | Phase 1/Phase 2 | Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers | April 2023 | May 2026 |
| NCT06363201 | Not yet recruiting | N/A | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | April 28, 2024 | December 15, 2025 |
| NCT05885984 | Not yet recruiting | N/A | Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT) | July 2023 | January 2024 |
| NCT05917990 | Not yet recruiting | N/A | Dyadic Text-Messaging Micro-Intervention | May 2024 | July 2026 |
| NCT05988697 | Not yet recruiting | Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib | November 1, 2023 | April 1, 2027 | |
| NCT06001749 | Not yet recruiting | Phase 2 | Psilocybin in Cancer Pain Study | July 2024 | December 31, 2026 |
| NCT06190886 | Not yet recruiting | Phase 1 | A First-in-human (FIH), Multicenter, Open-Label, Phase I Study of PTX-912 in Patients With Locally Advanced/Metastatic Solid Tumors | April 27, 2024 | July 24, 2026 |
| NCT06416085 | Not yet recruiting | Phase 2 | Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer | June 1, 2024 | June 15, 2026 |
| NCT06093425 | Not yet recruiting | Phase 3 | Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma | October 31, 2023 | January 31, 2026 |
| NCT06067087 | Not yet recruiting | Prognostic Understanding in ESC (ProgESC Study) | November 15, 2023 | October 31, 2024 | |
| NCT04599608 | Not yet recruiting | Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients | February 2021 | January 2026 | |
| NCT06082128 | Not yet recruiting | N/A | FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers | December 2023 | August 2025 |
| NCT06420609 | Not yet recruiting | N/A | Efficacy of a Proactive Approach to Death Thoughts in People With Advanced Cancer | May 14, 2024 | December 21, 2025 |
| NCT06457997 | Not yet recruiting | Phase 1 | A Study of PHN-010 in Patients With Advanced Solid Tumors | July 2024 | July 2027 |
| NCT06389097 | Not yet recruiting | SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization | May 2024 | May 2029 | |
| NCT05735496 | Not yet recruiting | Phase 1 | Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers | February 2023 | October 2024 |
| NCT05408507 | Recruiting | N/A | Care Planning Framework in Advanced Cancer (ABC123) | February 15, 2022 | December 2026 |
| NCT00515060 | Recruiting | Psychophysical Studies of Cancer Therapy Pain | January 23, 2001 | April 30, 2025 | |
| NCT02112188 | Recruiting | Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer | April 2014 | February 15, 2025 | |
| NCT02628067 | Recruiting | Phase 2 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | December 18, 2015 | May 4, 2027 |
| NCT03129139 | Recruiting | Phase 1 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | October 10, 2017 | December 1, 2024 |
| NCT03175224 | Recruiting | Phase 2 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | September 27, 2017 | November 30, 2026 |
| NCT03391479 | Recruiting | Phase 2 | A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy | August 15, 2018 | December 31, 2024 |
| NCT03503149 | Recruiting | Molecular Tumor Board at the Center for Personalized Medicine Tübingen | March 1, 2018 | March 1, 2028 | |
| NCT03605771 | Recruiting | Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain | August 7, 2018 | December 2024 | |
| NCT03785249 | Recruiting | Phase 1/Phase 2 | Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 | December 26, 2018 | January 2026 |
| NCT03810339 | Recruiting | Phase 2 | Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors | January 15, 2019 | January 15, 2024 |
| NCT03829254 | Recruiting | Phase 1/Phase 2 | A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma | June 17, 2019 | June 2024 |
| NCT03832855 | Recruiting | Phase 1 | Assessing the Immunogenicity of pING-hHER3FL | July 13, 2020 | September 1, 2025 |
| NCT03860272 | Recruiting | Phase 1 | Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer | April 1, 2019 | December 2026 |
| NCT03875781 | Recruiting | Phase 3 | Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer | June 5, 2019 | December 5, 2026 |
| NCT04095208 | Recruiting | Phase 2 | Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study | February 27, 2020 | December 2025 |
| NCT04146298 | Recruiting | Phase 1/Phase 2 | Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer | October 21, 2021 | March 2025 |
| NCT04204434 | Recruiting | Biomarkers For Immune Checkpoint Inhibitors | November 29, 2016 | September 2024 | |
| NCT04237805 | Recruiting | Phase 1/Phase 2 | A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients | November 14, 2016 | March 31, 2026 |
| NCT04321954 | Recruiting | Phase 2 | Lenvatinib in Locally Advanced Invasive Thyroid Cancer | March 9, 2021 | March 2025 |
| NCT04354246 | Recruiting | Phase 1 | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies | March 31, 2020 | March 30, 2025 |
| NCT04396821 | Recruiting | Phase 1/Phase 2 | A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | May 28, 2020 | December 31, 2024 |
| NCT04406662 | Recruiting | Routine Evaluation of People Living With Cancer | July 15, 2020 | August 8, 2029 | |
| NCT04407013 | Recruiting | N/A | Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway | June 23, 2020 | February 2024 |
| NCT04419532 | Recruiting | Phase 1 | A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors | October 9, 2020 | December 31, 2024 |
| NCT04467593 | Recruiting | N/A | Safety Study of Whole Body Hyperthermia for Advanced Cancer | July 28, 2021 | December 2024 |
| NCT04495296 | Recruiting | Phase 1/Phase 2 | A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors | August 13, 2020 | November 1, 2024 |
| NCT04495790 | Recruiting | AIMS Cancer Outcomes Study | May 18, 2020 | December 31, 2030 | |
| NCT04590885 | Recruiting | N/A | Coping Together: Couple-based Interventions for Cancer | October 20, 2020 | December 31, 2024 |
| NCT04606238 | Recruiting | N/A | Decision Aid to Support Advanced Cancer Patients | October 1, 2019 | April 1, 2023 |
| NCT04648202 | Recruiting | Phase 1 | FS120 Phase 1/1b Study in Patients With Advanced Malignancies | November 18, 2020 | March 1, 2026 |
| NCT04648254 | Recruiting | Phase 1 | Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor | November 18, 2020 | February 28, 2025 |
| NCT04657068 | Recruiting | Phase 1/Phase 2 | A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors | December 13, 2020 | June 2025 |
| NCT04672603 | Recruiting | N/A | Complete Versus Partial Preservation of Denonvilliers' Fascia on Urogenital Function in Locally Advanced Rectal Cancer | April 8, 2021 | May 1, 2025 |
| NCT04740424 | Recruiting | Phase 1 | FS222 First in Human Study in Patients With Advanced Malignancies | December 14, 2020 | May 2025 |
| NCT04757155 | Recruiting | N/A | Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM) | October 13, 2021 | January 31, 2025 |
| NCT04823377 | Recruiting | N/A | Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. | September 24, 2021 | September 20, 2026 |
| NCT04833023 | Recruiting | Phase 3 | HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial | May 18, 2022 | December 2024 |
| NCT04840004 | Recruiting | Phase 2 | Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer | March 10, 2021 | December 31, 2025 |
| NCT04900818 | Recruiting | Phase 1 | Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors | June 29, 2021 | December 2024 |
| NCT04936568 | Recruiting | N/A | Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease | July 14, 2021 | December 2023 |
| NCT05004116 | Recruiting | Phase 1/Phase 2 | A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer | August 9, 2021 | August 2028 |
| NCT05028218 | Recruiting | Phase 1 | A Clinical Study of TQB3824 in Subjects With Advanced Cancer | August 31, 2021 | December 2024 |
| NCT05045040 | Recruiting | N/A | Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions | September 6, 2021 | September 2023 |
| NCT05060432 | Recruiting | Phase 1/Phase 2 | Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors | September 6, 2021 | January 2025 |
| NCT05076552 | Recruiting | Phase 1 | A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer | February 17, 2023 | July 2025 |
| NCT05076760 | Recruiting | Phase 1 | MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer | February 23, 2022 | November 2026 |
| NCT05082259 | Recruiting | Phase 1 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | March 2, 2022 | March 16, 2026 |
| NCT05113199 | Recruiting | N/A | Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer | November 18, 2021 | October 31, 2025 |
| NCT05159245 | Recruiting | Phase 2 | The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs | December 10, 2021 | November 25, 2026 |
| NCT05166694 | Recruiting | N/A | Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions | November 30, 2022 | November 1, 2025 |
| NCT05192512 | Recruiting | Phase 1 | Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers | January 24, 2022 | January 2025 |
| NCT05204147 | Recruiting | Phase 1 | Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers | June 2, 2022 | August 7, 2025 |
| NCT05257590 | Recruiting | Phase 2 | CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma | May 23, 2022 | March 31, 2026 |
| NCT05270213 | Recruiting | Phase 1 | Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors | July 11, 2022 | October 2025 |
| NCT05276310 | Recruiting | Phase 1 | A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy | May 10, 2022 | December 31, 2026 |
| NCT05315999 | Recruiting | Phase 2 | Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care | May 3, 2022 | May 2025 |
| NCT05320588 | Recruiting | Phase 1/Phase 2 | A Study in Patients With Advanced Cancers | March 25, 2022 | April 2027 |
| NCT05375994 | Recruiting | Phase 1/Phase 2 | Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients | August 1, 2022 | January 1, 2025 |
| NCT05394103 | Recruiting | Phase 1/Phase 2 | Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors | August 30, 2022 | August 30, 2026 |
| NCT05394675 | Recruiting | Phase 1 | A Study of DS-9606a in Patients With Advanced Solid Tumors | May 31, 2022 | February 19, 2026 |
| NCT05398484 | Recruiting | Phase 2/Phase 3 | Psilocybin Therapy in Advanced Cancer | May 24, 2023 | January 1, 2027 |
| NCT05403801 | Recruiting | N/A | STAMP+CBT mHealth for Cancer Pain | July 1, 2022 | December 31, 2023 |
| NCT05420519 | Recruiting | Phase 1 | Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer | December 31, 2021 | December 31, 2024 |
| NCT05426330 | Recruiting | Advanced Cancer Patients' and Their Primary Caregivers' Willingness to Communicate About Advance Care Planning (ACP) | October 4, 2021 | October 4, 2024 | |
| NCT05450419 | Recruiting | N/A | The Role of Vitamin D3 Supplementation in Advanced Cancer Patients With Pain | July 1, 2021 | June 30, 2025 |
| NCT05498597 | Recruiting | Phase 1 | AMT-151 in Patients With Selected Advanced Solid Tumours | January 25, 2023 | October 30, 2024 |
| NCT05500508 | Recruiting | Phase 1/Phase 2 | Oral AMXT 1501 Dicaprate in Combination With IV DFMO | November 29, 2022 | September 30, 2024 |
| NCT05557045 | Recruiting | Phase 1 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 | October 10, 2022 | April 1, 2028 |
| NCT05584111 | Recruiting | Phase 1 | Oral Administration of STC-15 in Subjects With Advanced Malignancies | November 15, 2022 | May 30, 2025 |
| NCT05605509 | Recruiting | Phase 2 | RP-6306 in Patients With Advanced Cancer | May 24, 2023 | June 2025 |
| NCT05714553 | Recruiting | Phase 1/Phase 2 | NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours | March 8, 2023 | January 2025 |
| NCT05735080 | Recruiting | Phase 1/Phase 2 | Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer | March 28, 2023 | June 2026 |
| NCT05782361 | Recruiting | Phase 1 | POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC | May 3, 2023 | February 1, 2028 |
| NCT05802420 | Recruiting | N/A | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer | February 1, 2023 | February 1, 2025 |
| NCT05812677 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | February 6, 2023 | February 6, 2026 |
| NCT05853575 | Recruiting | Phase 2 | Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) | February 1, 2024 | September 2025 |
| NCT05859074 | Recruiting | Phase 1 | A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer | May 4, 2023 | May 4, 2028 |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT05877430 | Recruiting | Phase 1/Phase 2 | Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer | September 11, 2023 | October 2027 |
| NCT05884788 | Recruiting | Study of the Life Stories of Patients Making a Request for Euthanasia, in the Context of Advanced Cancer. | June 1, 2023 | March 2024 | |
| NCT05891171 | Recruiting | Phase 1 | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers | October 13, 2023 | August 2025 |
| NCT05894421 | Recruiting | Phase 1 | TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers | June 6, 2023 | January 2026 |
| NCT05971277 | Recruiting | Home And Locally Observed - Tracking (HALO-Trak) | January 30, 2023 | April 1, 2026 | |
| NCT06010875 | Recruiting | Phase 1 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | November 30, 2023 | September 30, 2026 |
| NCT06081517 | Recruiting | Evaluating Disparities in Precision Oncology | January 26, 2024 | July 2029 | |
| NCT06092580 | Recruiting | Phase 1 | Phase 1 Study of AWT020 in Advanced Cancer | September 15, 2023 | September 15, 2025 |
| NCT06120075 | Recruiting | Phase 1 | A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies | January 19, 2024 | November 2026 |
| NCT06174987 | Recruiting | Phase 3 | A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) | January 5, 2024 | August 3, 2026 |
| NCT06188624 | Recruiting | Phase 1 | Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers | February 1, 2024 | December 2025 |
| NCT06200155 | Recruiting | Phase 2 | Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy | April 16, 2024 | December 31, 2026 |
| NCT06210776 | Recruiting | A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH) | January 15, 2024 | March 1, 2028 | |
| NCT06215950 | Recruiting | Phase 1 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer | January 10, 2024 | December 31, 2027 |
| NCT06227728 | Recruiting | Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. | March 22, 2024 | December 31, 2026 | |
| NCT06228326 | Recruiting | Phase 1 | A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | April 17, 2024 | February 2027 |
| NCT06229158 | Recruiting | Assessment of the Quality and Sexual Health Needs of Patients With Advanced-stage Cancer | February 5, 2024 | September 13, 2024 | |
| NCT06239467 | Recruiting | Phase 1 | First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer | March 1, 2024 | August 1, 2027 |
| NCT06240767 | Recruiting | Phase 1 | Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils | November 1, 2023 | December 31, 2025 |
| NCT06242470 | Recruiting | Phase 1 | A Study of MGC026 in Participants With Advanced Solid Tumors | March 6, 2024 | October 2028 |
| NCT06285500 | Recruiting | Umbrella Study for Single Patient Treatments in Oncology | February 1, 2024 | February 1, 2029 | |
| NCT06302140 | Recruiting | Phase 1 | A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers | February 28, 2024 | October 2025 |
| NCT06338683 | Recruiting | Phase 3 | Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer | March 20, 2024 | March 20, 2028 |
| NCT06362369 | Recruiting | Phase 1/Phase 2 | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy | May 20, 2024 | December 31, 2028 |
| NCT06405490 | Recruiting | Phase 2 | NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC | April 17, 2024 | December 30, 2026 |
| NCT06440005 | Recruiting | Phase 1 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | May 2024 | May 2027 |
| NCT02130492 | Suspended | Phase 1/Phase 2 | A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) | May 2014 | July 2025 |
| NCT04001010 | Suspended | Phase 3 | Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia | July 2022 | December 2023 |
| NCT00607711 | Suspended | Phase 1 | Study of Oral Palifosfamide Tris in Solid Tumors | March 2008 | November 2009 |
| NCT03722186 | Suspended | Phase 1 | Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies | November 13, 2018 | October 2021 |
| NCT03120130 | Suspended | Phase 1 | Study of Amblyomin-X in Advanced Solid Tumor | February 15, 2021 | May 22, 2022 |
| NCT02318901 | Terminated | Phase 1/Phase 2 | Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer | October 2014 | August 2018 |
| NCT00684242 | Terminated | Phase 2 | Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain | May 2008 | October 2011 |
| NCT04250597 | Terminated | Phase 1 | Study of GNX102 in Patients With Advanced Solid Tumors | July 29, 2020 | July 26, 2023 |
| NCT01545921 | Terminated | N/A | Cancer End Of Life Evaluation | November 11, 2011 | June 6, 2019 |
| NCT01185548 | Terminated | Phase 1 | A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma | July 2010 | December 2010 |
| NCT03110107 | Terminated | Phase 1/Phase 2 | First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors | May 4, 2017 | April 4, 2024 |
| NCT00606879 | Terminated | Phase 1 | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors | January 2008 | June 2009 |
| NCT01209832 | Terminated | Phase 1 | A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients | September 2010 | January 2011 |
| NCT05525455 | Terminated | Phase 1/Phase 2 | TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88) | August 29, 2022 | September 7, 2023 |
| NCT00895024 | Terminated | Caregiver Assessments of the Quality of Home Hospice Care | April 2009 | September 28, 2020 | |
| NCT03582618 | Terminated | Phase 2 | CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma | July 12, 2018 | December 30, 2022 |
| NCT02580045 | Terminated | Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer | April 1, 2016 | February 22, 2018 | |
| NCT00504985 | Terminated | Fatigue in Emergency Center Patients | August 2005 | April 2008 | |
| NCT03525392 | Terminated | Phase 1 | Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. | May 3, 2018 | April 28, 2021 |
| NCT00729833 | Terminated | Phase 1 | Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors | September 2008 | April 2013 |
| NCT03002831 | Terminated | Phase 2 | Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer | November 2016 | October 2019 |
| NCT02554812 | Terminated | Phase 1/Phase 2 | A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) | November 9, 2015 | March 23, 2023 |
| NCT00634010 | Terminated | Phase 3 | Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain | February 2008 | January 2015 |
| NCT03444753 | Terminated | Phase 1 | An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed | April 5, 2018 | February 14, 2022 |
| NCT02992977 | Terminated | Phase 1 | Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer | January 2017 | December 2019 |
| NCT00529230 | Terminated | Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes | December 11, 2001 | February 19, 2004 | |
| NCT00430014 | Terminated | Phase 1 | Study of Atiprimod Treatment for Patients With Advanced Cancer | March 2005 | February 2012 |
| NCT01347866 | Terminated | Phase 1 | Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer | October 2011 | December 2015 |
| NCT00625742 | Terminated | N/A | Multimodal Treatment Strategy for Cancer Cachexia | February 2008 | June 2014 |
| NCT01887041 | Terminated | Phase 4 | Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer | January 2010 | December 2015 |
| NCT02136342 | Terminated | Phase 1 | Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer | May 2014 | |
| NCT04441099 | Terminated | Phase 1/Phase 2 | NBE-002 in Patients With Advanced Solid Tumors | June 19, 2020 | August 14, 2023 |
| NCT00352664 | Terminated | Phase 3 | The Effect of Donepezil on Sedation and Other Symptoms | November 2003 | July 2007 |
| NCT00385775 | Terminated | Phase 1 | Study of XIAP Antisense for Advanced Cancers | June 2006 | November 2008 |
| NCT02805660 | Terminated | Phase 1/Phase 2 | Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC | June 1, 2016 | December 20, 2019 |
| NCT00607399 | Terminated | Phase 1 | Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors | January 2008 | June 2009 |
| NCT02750514 | Terminated | Phase 2 | An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer | May 9, 2016 | January 29, 2020 |
| NCT01688791 | Terminated | Phase 1 | A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) | December 2012 | September 2014 |
| NCT02801097 | Terminated | Phase 1 | RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) | August 30, 2016 | December 9, 2019 |
| NCT00704821 | Terminated | Phase 1 | PTC299 for Treatment of Advanced Cancer | July 3, 2008 | February 24, 2012 |
| NCT01394003 | Terminated | Phase 1 | A Study of LY2584702 in Participants With Advanced Cancer | November 2008 | April 2011 |
| NCT05128539 | Terminated | Phase 1 | A Study Explore JS001+JS002 in Patients With Advanced Cancer | February 10, 2022 | November 10, 2023 |
| NCT02423954 | Terminated | Phase 1/Phase 2 | Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | April 2015 | November 1, 2017 |
| NCT02341625 | Terminated | Phase 1/Phase 2 | A Study of BMS-986148 in Patients With Select Advanced Solid Tumors | June 19, 2015 | May 7, 2020 |
| NCT02331251 | Terminated | Phase 1/Phase 2 | Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) | December 2014 | January 2018 |
| NCT03258541 | Terminated | N/A | Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy | January 15, 2017 | May 2020 |
| NCT01929941 | Terminated | Phase 1 | An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies | September 2013 | August 2014 |
| NCT03690154 | Terminated | Phase 1 | A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML | July 23, 2018 | February 11, 2022 |
| NCT02671955 | Terminated | Phase 1 | A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer | January 2016 | July 2017 |
| NCT00832520 | Terminated | Phase 2 | Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight | November 2008 | June 2011 |
| NCT05154630 | Terminated | Phase 1/Phase 2 | Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors | January 14, 2022 | June 30, 2023 |
| NCT01744249 | Unknown status | Phase 2/Phase 3 | Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas | November 2011 | October 2021 |
| NCT04942756 | Unknown status | N/A | GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. | June 30, 2021 | June 30, 2022 |
| NCT00792896 | Unknown status | N/A | Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease | May 2008 | |
| NCT01527331 | Unknown status | N/A | A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer | June 2011 | |
| NCT05136937 | Unknown status | Phase 1 | A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors | November 1, 2021 | June 1, 2023 |
| NCT01983956 | Unknown status | N/A | A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial) | December 23, 2013 | April 25, 2020 |
| NCT03811379 | Unknown status | Phase 2 | Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy | November 21, 2018 | December 30, 2021 |
| NCT05142345 | Unknown status | N/A | Care Transition Intervention for Hospitalized Patients With Advanced Cancer | December 15, 2021 | December 2023 |
| NCT03900442 | Unknown status | Phase 1 | Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort | September 1, 2019 | April 30, 2023 |
| NCT03922204 | Unknown status | Phase 1 | A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies | May 8, 2019 | December 2022 |
| NCT03645200 | Unknown status | Phase 1 | Treatment of Carrying TP53 Harmful Mutations | July 1, 2019 | June 1, 2020 |
| NCT03554889 | Unknown status | Phase 1 | Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells | August 1, 2018 | November 27, 2019 |
| NCT03546426 | Unknown status | Phase 1 | Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies | December 12, 2019 | January 2024 |
| NCT03986515 | Unknown status | Phase 2 | Apatinib Plus SHR1210 in Advanced Mucosal Melanoma | June 4, 2019 | May 31, 2022 |
| NCT03518970 | Unknown status | N/A | Uncertainty in Illness in Palliative Care: an Intervention for Family Caregivers | August 1, 2018 | March 1, 2019 |
| NCT04042597 | Unknown status | Phase 2 | Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma | July 18, 2019 | December 31, 2021 |
| NCT03387436 | Unknown status | N/A | The "Hand-in-Hand Study": Improvement of Quality of Life in Palliative Cancer Patients Through Collaborative Advance Care Planning | December 4, 2017 | September 1, 2020 |
| NCT03325218 | Unknown status | Survival Expectations and Hope Among Cancer Patients at End-of-Life | April 1, 2018 | August 31, 2021 | |
| NCT04089306 | Unknown status | Integration of Palliative Care in an Oncology and Hematology Unit | October 1, 2019 | May 2020 | |
| NCT04110223 | Unknown status | Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors | October 8, 2018 | October 8, 2021 | |
| NCT04121039 | Unknown status | Phase 2 | Study of the Apatinib Combine With POF Versus POF in Gastric Cancer | December 2019 | December 2023 |
| NCT03261011 | Unknown status | Phase 1 | Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors | October 3, 2017 | September 2020 |
| NCT04124666 | Unknown status | Phase 1/Phase 2 | Clinical Study of Granulocyte Infusion for Advanced Cancer | December 1, 2019 | September 30, 2022 |
| NCT04141397 | Unknown status | Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care | July 1, 2014 | December 31, 2021 | |
| NCT03243643 | Unknown status | Phase 1 | Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors | August 8, 2017 | December 2019 |
| NCT03221400 | Unknown status | Phase 1/Phase 2 | PEN-866 in Patients With Advanced Solid Malignancies | August 29, 2017 | June 2023 |
| NCT03219775 | Unknown status | Phase 2 | Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma | July 6, 2017 | February 18, 2023 |
| NCT01361529 | Unknown status | Phase 1 | Safety Study of FLP Injection to Treat Tumor Patients | June 2009 | July 2011 |
| NCT04257786 | Unknown status | N/A | Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer | March 1, 2020 | April 1, 2022 |
| NCT03099330 | Unknown status | Phase 1 | A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics | July 19, 2017 | December 2018 |
| NCT04308356 | Unknown status | Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? | June 3, 2020 | June 2022 | |
| NCT03030001 | Unknown status | Phase 1/Phase 2 | PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies | February 15, 2017 | February 1, 2019 |
| NCT04317651 | Unknown status | Crizotinib in ALK Rearranged Non-small-cell Lung Cancer | May 16, 2019 | June 2022 | |
| NCT04318808 | Unknown status | N/A | Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer | March 1, 2020 | August 2022 |
| NCT00214838 | Unknown status | Phase 1/Phase 2 | An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer | March 2005 | March 2007 |
| NCT03019276 | Unknown status | Phase 1 | A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics | July 5, 2017 | December 2018 |
| NCT03008109 | Unknown status | Phase 3 | Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC | February 2017 | November 2018 |
| NCT02996838 | Unknown status | Phase 1 | A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics | May 11, 2017 | December 2020 |
| NCT04376931 | Unknown status | Phase 1/Phase 2 | A Prospective Dose Finding Study of Iscador Infusion | December 1, 2020 | July 1, 2023 |
| NCT04385654 | Unknown status | Phase 2 | Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma | June 2020 | June 2022 |
| NCT04398875 | Unknown status | N/A | Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial | September 1, 2020 | August 31, 2023 |
| NCT02944864 | Unknown status | Phase 1 | A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics | August 13, 2017 | October 2018 |
| NCT00591422 | Unknown status | Phase 1 | Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas | August 2007 | June 2013 |
| NCT02797795 | Unknown status | Phase 1 | A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers | December 2016 | December 2021 |
| NCT02779699 | Unknown status | Phase 1 | A Study of AL2846 on Tolerance and Pharmacokinetics | May 2016 | October 2020 |
| NCT01313247 | Unknown status | Phase 4 | Paracetamol for Cancer Pain | April 2011 | December 2012 |
| NCT02684318 | Unknown status | Phase 1/Phase 2 | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors | July 2015 | October 2019 |
| NCT01611961 | Unknown status | Phase 1 | Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients | August 2012 | December 2014 |
| NCT05438342 | Unknown status | N/A | An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis | November 1, 2021 | October 31, 2023 |
| NCT04859777 | Unknown status | Phase 1 | A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors | April 13, 2021 | March 2023 |
| NCT02469883 | Unknown status | Phase 1 | A Study of Sinotecean on Tolerance and Pharmacokinetics | March 2015 | December 2016 |
| NCT04943627 | Withdrawn | Phase 3 | Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA) | August 2, 2021 | October 22, 2021 |
| NCT02432612 | Withdrawn | Phase 1 | A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer | October 2015 | October 2016 |
| NCT03122249 | Withdrawn | N/A | Oncology Associated Symptoms & Individualized Strategies | March 10, 2017 | September 20, 2019 |
| NCT04158700 | Withdrawn | Phase 1/Phase 2 | A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer | December 5, 2019 | May 11, 2023 |
| NCT03671720 | Withdrawn | Early Phase 1 | Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden | September 11, 2018 | December 30, 2022 |
| NCT03904342 | Withdrawn | N/A | Sophie Pilot Implementation and Assessment | January 2021 | December 2021 |
| NCT04584775 | Withdrawn | N/A | Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care | February 2021 | July 2022 |
| NCT02915172 | Withdrawn | Phase 1 | Lenvatinib and Capecitabine in Patients With Advanced Malignancies | December 2016 | |
| NCT02261051 | Withdrawn | Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm | October 2014 | September 2015 | |
| NCT05262842 | Withdrawn | Phase 1 | JS001+IMP4297 in Patients With Advanced Cancer | March 29, 2022 | June 6, 2024 |
| NCT03104335 | Withdrawn | Phase 2 | Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial | April 1, 2017 | March 1, 2020 |
| NCT02747797 | Withdrawn | Phase 2 | Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations | April 2017 | April 2022 |